Serum CA-125 elevation associated with ovarian endometriosis

Gynaecological Endoscopy

Volumn 5, Issue 1, 1996, Pages 51-52

  Kowalczyk, Carole ^a   Doty, Angela ^a   Ginsburg, Kenneth A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CA 125; Endometriosis; Ovarian cancer; Ovarian endometrioma

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ENDOMETRIOSIS; FEMALE; HUMAN; OVARY DISEASE; PRIORITY JOURNAL;

EID: 0030030659     PISSN: 09621091     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2508.1996.235195.x     Document Type: Article

References (4)

1. Disaia PJ, Creasman WT. Advanced epithelial ovarian cancer. In: Clinical Gynecologic Oncology. St Louis: Mosby Year Book, 1989: 325-416.
2. Soper JT, Hunter VJ, Daly L, Tanner M, Creasman WT, Bast RC. Preoperative serum tumor-associated antigen levels in women with pelvic masses. Obstetrics and Gynecology 1990; 75: 249-54.
3. Kauppila A, Telimar S, Ronnberg, L, Vauri, J. Placebo controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate. Fertility and Sterility 1988; 49: 37.
4. Check JH, Coates TE, Nowroozi K. Extreme elevation of serum CA-125 in two women with severe endometriosis: case report. Gynecologic Endocrinology 1991; 5: 217-9.